CMS Clarifies CLIA Certification Requirements for Remote Cytology

TELCOR Apr 1, 2026

Industry RCM
CMS Clarifies CLIA Certification Requirements for Remote Cytology

The Centers for Medicare & Medicaid Services (CMS) recently clarified Clinical Laboratory Improvement Act (CLIA) certification requirements for remote cytology.

The College of American Pathologists (CAP) requested clarification because of recent federal policy updates, including updates to requirements related to CLIA certification for laboratories. CMS officials explained that remote Rapid Adequacy Assessments (also known as rapid on-site evaluation or ROSE) require a separate CLIA certificate for an off-site location where a review is performed, including virtual slide review. CMS also clarified that adequacy assessment does not count as a separate examination for workload limit purposes.

Source:

https://www.cap.org/advocacy/latest-news-and-practice-data/march-31-2026#story2
Organizations Representing Clinical Labs and Diagnostics Write in Support of Legislation to Improve Medicare LCD Process

Organizations Representing Clinical Labs and Diagnostics Write in Support of Legislation to Improve Medicare LCD Process

TELCOR: Aug 13, 2026

A coalition of more than 30 stakeholder organizations has written to key lawmakers expressing their support for the Timely Access to Coverage...

Industry RCM
Read More
Congressional Problem Solvers Caucus Endorses RESULTS Act

Congressional Problem Solvers Caucus Endorses RESULTS Act

TELCOR: Aug 5, 2026

A bipartisan congressional caucus recently announced its endorsement of the Reforming and Enhancing Sustainable Updates to Laboratory Testing...

Industry RCM
Read More
Senate HELP Committee Votes to Advance Price Transparency Legislation

Senate HELP Committee Votes to Advance Price Transparency Legislation

TELCOR: Jul 29, 2026

On July 22, the Senate Health, Education, Labor, and Pensions (HELP) Committee voted to advance the Patients Deserve Price Tags Act (S.2355) by a...

Industry RCM
Read More